Healthtech company House Rx announced on Monday a new AI capability designed to streamline one of the most time-consuming and error-prone steps in the specialty drug process: prior authorisations.

The company says that using generative AI, House Rx retrieves payor question sets and pre-fills responses based on patient documentation within the electronic health records – all within its platform. This eliminates the need for expensive third-party tools and keeps the entire prior authorisation workflow centralised and transparent.

With the House Rx platform, clinics can generate answers for a prior authorisation within 15 seconds and submit in less than 60 seconds, and 92% of prior authorisations submitted through House Rx's platform are approved on the first submission.

House Rx will debut its AI-enabled technology at the Community Oncology Conference taking place from 29-30 April in Orlando, Florida.